首站-论文投稿智能助手
典型文献
Prognostic Evaluation for Oral Squamous Cell Carcinoma:A Novel Method Based on m6A Methylation Regulators
文献摘要:
Objective:This study aimed to examine a novel method for prognostic evaluation of patients with oral squamous cell carcinoma(OSCC)based on the expression of heterogeneous nuclear ribonucleoprotein C(HNRNPC),YTH domain-binding protein 2(YTHDF2),and methyltransferase 14(METTL14).Methods:We obtained the RNA sequence and clinical information of OSCC patients from The Cancer Genome Atlas database.An optical method was established by the least absolute shrinkage and selection operator Cox regression algorithm,which was used to calculate the risk score of every sample.In addition,all samples(n=239)were classified into high-risk(n=119)and low-risk(n=120)groups,and the overall survival(OS)time and clinical characteristics were compared between groups.Moreover,bioinformatics analysis was carried out.Gene set enrichment analysis was performed to investigate the signaling pathways of HNRNPC,YTHDF2,and METTL14.Results:The two groups showed significantly different OS time,tumor grades,tumor stages,and pathologic T stages(P<0.05).The receiver operating characteristic analysis identified that our method was effective and it was more accurate than use of age,gender,tumor grade,tumor stage,pathologic T stage,and pathologic N stage in OSCC prognostic prediction.Gene set enrichment analysis revealed that HNRNPC,YTHDF2,and METTL14 were mainly associated with ubiquitin-mediated proteolysis,cell cycle,RNA degradation,and spliceosome signaling pathways.Conclusion:The method based on the expression of HNRNPC,YTHDF2,and METTL14 can predict the prognosis of patients with OSCC independently,and its prognostic value is better than that of clinicopathological characteristic indicators.
文献关键词:
作者姓名:
Li XU;Cheng YU;Xi-jin DU
作者机构:
Department of Stomatology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
引用格式:
[1]Li XU;Cheng YU;Xi-jin DU-.Prognostic Evaluation for Oral Squamous Cell Carcinoma:A Novel Method Based on m6A Methylation Regulators)[J].当代医学科学(英文),2022(04):841-846
A类:
B类:
Prognostic,Evaluation,Oral,Squamous,Cell,Carcinoma,Novel,Based,m6A,Methylation,Regulators,Objective,This,study,aimed,examine,novel,method,prognostic,evaluation,patients,oral,squamous,cell,carcinoma,OSCC,expression,heterogeneous,nuclear,ribonucleoprotein,HNRNPC,domain,binding,YTHDF2,methyltransferase,METTL14,Methods,We,obtained,sequence,clinical,information,from,Cancer,Genome,Atlas,database,An,optical,was,established,by,least,absolute,shrinkage,selection,operator,Cox,regression,algorithm,which,used,calculate,risk,score,every,In,addition,samples,were,classified,into,high,low,groups,overall,survival,characteristics,compared,between,Moreover,bioinformatics,analysis,carried,out,Gene,set,enrichment,performed,investigate,signaling,pathways,Results,two,showed,significantly,different,tumor,grades,stages,receiver,operating,identified,that,our,effective,more,accurate,than,gender,prediction,revealed,mainly,associated,ubiquitin,mediated,proteolysis,cycle,degradation,spliceosome,Conclusion,prognosis,independently,its,value,better,clinicopathological,indicators
AB值:
0.574121
相似文献
A New Coronavirus Estimation Global Score for Predicting Mortality During Hospitalization in Patients with COVID-19
Zeng Hesong;He Xingwei;Liu Wanjun;Kan Jing;He Liqun;Zhao Jinhe;Chen Cynthia;Zhang Junjie;Chen Shaoliang-Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei 430030, China;Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, China;Division of Cardiology, Wuhan First Hospital, Wuhan, Hubei 430022, China;Division of Cardiology, Tianyou Hospital affiliated to Wuhan University of Science & Technology, Wuhan, Hubei 430064, China;Mailman School of Public Health, Columbia University, New York, New York 10027, USA;College of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 210002, China
Establishment and Evaluation of a Prediction Model of BLR for Severity in Coronavirus Disease 2019
He Zebao;Rui Fajuan;Yang Hongli;Ge Zhengming;Huang Rui;Ying Lingjun;Zhao Haihong;Wu Chao;Li Jie-Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, Zhejiang 317099, China;Department of Infectious Diseases, Enze Hospital, Taizhou Enze Medical Center (Group), Taizhou, Zhejiang 318053, China;Department of Infectious Disease, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong 250021, China;Department of Infectious Disease, Cheeloo College of Medicine, Shandong University, Ji’nan, Shandong 250012, China;Department of Infectious Diseases, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu 210008, China;Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu 210033, China
A Predictive Nomogram for Predicting Improved Clinical Outcome Probability in Patients with COVID-19 in Zhejiang Province,China
Jiaojiao Xie;Ding Shi;Mingyang Bao;Xiaoyi Hu;Wenrui Wu;Jifang Sheng;Kaijin Xu;Qing Wang;Jingjing Wu;Kaicen Wang;Daiqiong Fang;Yating Li;Lanjuan Li-State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China;State Key Laboratory of Genetic Engineering,Institute of Biostatistics,School of Life Sciences,Fudan University,Shanghai 200433,China;Division of Hepatobiliary and Pancreatic Surgery,Department of Surgery,Key Lab of Combined Multi-organ Transplantation of the Ministry of Health,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China;Division of of Endocrinology and Metabolism,Department of Internal Medicine System,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China
Prediction of Driver Gene Matching in Lung Cancer NOG/PDX Models Based on Artificial Intelligence
Yayi He;Haoyue Guo;Li Diao;Yu Chen;Junjie Zhu;Hiran C.Fernando;Diego Gonzalez Rivas;Hui Qi;Chunlei Dai;Xuzhen Tang;Jun Zhu;Jiawei Dai;Kan He;Dan Chan;Yang Yang-School of Medicine,Tongji University,Shanghai 200092,China;Department of Medical Oncology,Shanghai Pulmonary Hospital,School of Medicine,Tongji University,Shanghai 200433,China;Department of Automation,School of Electronic Information and Electrical Engineering,Shanghai Jiao Tong University,Shanghai 200240,China;Spine Center,Orthopedic Department,Shanghai Changzheng Hospital,Shanghai 200003,China;Department of Thoracic Surgery,Shanghai Pulmonary Hospital,School of Medicine,Tongji University,Shanghai 200433,China;Department of Thoracic Surgery,Allegheny General Hospital,Pittsburgh,PA 15212,USA;Department of Thoracic Surgery and Minimally Invasive Thoracic Surgery Unit(UCTMI),Coruna University Hospital,Coruna 15006,Spain;Oncology and Immunology BU,Research Service Division,WuXi Apptec,Shanghai 200131,China;SJTU-Yale Joint Center for Biostatistics and Data Science,Department of Bioinformatics and Biostatistics,School of Life Sciences and Biotechnology,Shanghai Jiao Tong University,Shanghai 200240,China;Division of Medical Oncology,Department of Medicine,University of Colorado Anschutz Medical Campus,Aurora,CO 80045,USA;School of Materials Science and Engineering,Tongji University,Shanghai 201804,China
Associations of the Fat-age-inflammation Index with Overall Survival in Patients with Metastatic Lung Cancer
Na Li;Yu Jun Zhang;Chuan Chen;Wei Li;Chun Hua Song;Han Ping Shi;Hong Xia Xu;Liang Yu Yin-Department of Clinical Nutrition,Daping Hospital,Army Medical University(Third Military Medical University),Chongqing 400042,China;Institute of Hepatopancreatobiliary Surgery,Southwest Hospital,Army Medical University(Third Military Medical University),Chongqing 400038,China;Department of Cancer Center,Daping Hospital,Army Medical University(Third Military Medical University),Chongqing 400042,China;Cancer Center of the First Hospital of Jilin University,Changchun,Jilin 130021,China;Department of Epidemiology,College of Public Health,Zhengzhou University,Zhengzhou,Henan 450001,China;Department of Gastrointestinal Surgery and Department of Clinical Nutrition,Beijing Shijitan Hospital,Capital Medical University,Beijing 100038,China
Nutritional Risk Screening with NRS2002 among Hospitalized Cancer Patients in China
Ming Ming Zhou;Tian Tian Wu;Yu Han Wang;Yuan Lin Zou;Ke Di Xu;Jiu Wei Cui;Zeng Ning Li;Jun Qiang Chen;Ming Liu;Zeng Qing Guo;Hong Xia Xu;Han Ping Shi;Chun Hua Song;Investigation on Nutrition Status and Clinical Outcome of Common Cancers(INSCOC)Group-Department of Epidemiology and Statistics,College of Public Health,Zhengzhou University,Zhengzhou 450001,Henan,China;Cancer Center of the First Hospital of Jilin University,Changchun 130021,Jilin,China;Department of Clinical Nutrition,The First Hospital of Hebei Medical University,Shijiazhuang 050031,Hebei,China;Department of Gastrointestinal Surgery,First Affiliated Cancer Hospital of Guangxi Medical University,Nanning 530021,Guangxi,China;Department of General Surgery,The Fourth Affiliated Hospital,Harbin Medical University,Harbin 150000,Heilongjiang,China;Department of Medical Oncology,Fujian Cancer Hospital&Fujian Medical University Cancer Hospital,Fuzhou 350014,Fujian,China;Department of Clinical Nutrition,Daping Hospital,Army Medical University(Third Military Medical University),Chongqing 400042,China;Department of Gastrointestinal Surgery/Department of Clinical Nutrition,Beijing Shijitan Hospital,Capital Medical University,Beijing 100038,China;Key Laboratory of Cancer FSMP for State Market Regulation,Beijing 100038,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。